96 related articles for article (PubMed ID: 11696937)
1. Psychometric properties of the "Modified Transplant Symptom Occurrence and Symptom Distress Scale".
Moons P; De Geest S; Versteven K; Abraham I; Vlaminck H; Moens G; Waer M
J Nurs Meas; 2001; 9(2):115-34. PubMed ID: 11696937
[TBL] [Abstract][Full Text] [Related]
2. Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale.
Dobbels F; Moons P; Abraham I; Larsen CP; Dupont L; De Geest S
Transpl Int; 2008 Aug; 21(8):764-73. PubMed ID: 18435683
[TBL] [Abstract][Full Text] [Related]
3. Measuring symptom occurrence and symptom distress: development of the symptom experience index.
Fu MR; McDaniel RW; Rhodes VA
J Adv Nurs; 2007 Sep; 59(6):623-34. PubMed ID: 17672849
[TBL] [Abstract][Full Text] [Related]
4. Children's Emotional Manifestation Scale: development and testing.
Li HC; Lopez V
J Clin Nurs; 2005 Feb; 14(2):223-9. PubMed ID: 15669931
[TBL] [Abstract][Full Text] [Related]
5. Validation and adaptation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale-59 Items Revised into Turkish.
Ordin YS; Karayurt O; Cilengiroğlu OV
Prog Transplant; 2013 Dec; 23(4):392-400. PubMed ID: 24311405
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study.
Moons P; Vanrenterghem Y; Van Hooff JP; Squifflet JP; Margodt D; Mullens M; Thevissen I; De Geest S
Transpl Int; 2003 Sep; 16(9):653-64. PubMed ID: 12748758
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional survey of the symptom experience of kidney transplant recipients.
Lin YH; Yang MS
Int J Nurs Stud; 2007 Aug; 44(6):953-60. PubMed ID: 16712849
[TBL] [Abstract][Full Text] [Related]
8. Case-finding for depressive and exhausted mood in the general population: reliability and validity of a symptom-driven diagnostic scale. Results from the prospective MONICA/KORA Augsburg Study.
Ladwig KH; Marten-Mittag B; Baumert J; Löwel H; Döring A;
Ann Epidemiol; 2004 May; 14(5):332-8. PubMed ID: 15177272
[TBL] [Abstract][Full Text] [Related]
9. Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: possible relationship with medication non-compliance?
Drent G; Moons P; De Geest S; Kleibeuker JH; Haagsma EB
Clin Transplant; 2008; 22(6):700-9. PubMed ID: 18673378
[TBL] [Abstract][Full Text] [Related]
10. Symptom occurrence, symptom distress, and quality of life in renal transplant recipients.
Zarifian A
Nephrol Nurs J; 2006; 33(6):609-18; quiz 619. PubMed ID: 17219723
[TBL] [Abstract][Full Text] [Related]
11. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
[TBL] [Abstract][Full Text] [Related]
12. Hyperarousal, depression and quality of life--validity and reliability of the Swedish version of the Hyperarousal Scale.
Edéll-Gustafsson U; Carstensen J; Regestein Q; Swahn E; Svanborg E
Scand J Caring Sci; 2006 Mar; 20(1):58-67. PubMed ID: 16489961
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the ESRD Symptom Checklist--Transplantation Module in Norwegian kidney transplant recipients.
Stavem K; Ganss R
BMC Nephrol; 2006 Nov; 7():17. PubMed ID: 17109746
[TBL] [Abstract][Full Text] [Related]
14. Psychometric evaluation of the National Kidney Dialysis and Kidney Transplantation Study symptom checklist: reliability and validity.
Spiegel DM; Evans RW; Gitlin M; Mayne TJ
Nephrol Dial Transplant; 2009 Feb; 24(2):619-25. PubMed ID: 18799605
[TBL] [Abstract][Full Text] [Related]
15. Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey.
Kim SH; Oh EG; Lee WH
Int J Nurs Stud; 2006 Nov; 43(8):1047-56. PubMed ID: 16952363
[TBL] [Abstract][Full Text] [Related]
16. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
Jayasekara H; Rajapaksa LC; Greimel ER
Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
[TBL] [Abstract][Full Text] [Related]
17. Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.
Twiss C; Triaca V; Anger J; Patel M; Smith A; Kim JH; Raz S; Rodríguez LV
J Urol; 2009 Nov; 182(5):2384-91. PubMed ID: 19758631
[TBL] [Abstract][Full Text] [Related]
18. Distress associated with adverse effects of immunosuppressive medication in kidney transplant recipients.
Koller A; Denhaerynck K; Moons P; Steiger J; Bock A; De Geest S
Prog Transplant; 2010 Mar; 20(1):40-6. PubMed ID: 20397345
[TBL] [Abstract][Full Text] [Related]
19. [The "Medication Experience Scale for Immunosuppressants" (MESI): initial results for a new screening instrument in transplant medicine].
Goetzmann L; Klaghofer R; Spindler A; Wagner-Huber R; Scheuer E; Buddeberg C
Psychother Psychosom Med Psychol; 2006 Feb; 56(2):49-55. PubMed ID: 16453242
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an immunosuppressant therapy adherence barrier instrument.
Chisholm MA; Lance CE; Williamson GM; Mulloy LL
Nephrol Dial Transplant; 2005 Jan; 20(1):181-8. PubMed ID: 15572384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
